News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
Two NIH Technology Transfer experts will be speaking at the Biotechnology Innovation Organization 2025 International Convention taking place in Boston, June 16-19, 2025, with pre-conference sessions taking place June 14-15. Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer
Researchers at the NIH Clinical Center developed a new fungal-specific imaging ligand that exploits fungal-specific metabolic pathways absent in mammalian cells or bacteria to rapidly diagnose a live fungal infection in any patient and are seeking a collaborator to further develop this technology
World Intellectual Property (IP) Day is April 25th. This is a global event dedicated to industry inventors, creators, and entrepreneurs and how they achieve their goals through the use of IP. To celebrate, the Licensing Executives Society (LES) is hosting a free webinar to bring people together